BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lam GY, Halloran BP, Peters AC, Fedorak RN. Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders. World J Gastrointest Pathophysiol 2015; 6(4): 181-192 [PMID: 26600976 DOI: 10.4291/wjgp.v6.i4.181]
URL: https://www.wjgnet.com/2150-5330/full/v6/i4/181.htm
Number Citing Articles
1
H. Matthew Cohn, Maneesh Dave, Edward V. Loftus. Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2017; 23(8): 1301 doi: 10.1097/MIB.0000000000001199
2
Michihide Tokuhira, Jun-ichi Tamaru, Masahiro Kizaki. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disordersJournal of Clinical and Experimental Hematopathology 2019; 59(2): 72 doi: 10.3960/jslrt.19007
3
Yanhua Zhou, Yanlin Zhang, Haiying Zhao, Xuan Cui, Yongqiu Wei, Yongdong Wu, Shutian Zhang, Ye Zong. EBV-associated lymphoproliferative disorder involving the gastrointestinal tract which mimic IBD in immunocompetent patients: case reports and literature reviewInternational Journal of Colorectal Disease 2019; 34(11): 1989 doi: 10.1007/s00384-019-03400-4
4
Tarun Chhibba, Christopher Ma. Is there room for immunomodulators in ulcerative colitis?Expert Opinion on Biological Therapy 2020; 20(4): 379 doi: 10.1080/14712598.2020.1708896
5
Lydia Montes, Estelle Tredez, Clara Yzet, Caroline Delette, Denis Chatelain, Delphine Lebon, Mathurin Fumery, Jean‐Pierre Marolleau. Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30Clinical Case Reports 2020; 8(6): 958 doi: 10.1002/ccr3.2721
6
Adam Joseph Hardy, Ionica Stoica, David Edward Kearney, Diarmuid S O'Riordain. Diffuse large B-cell lymphoma of the rectum in a patient with Crohn’s diseaseBMJ Case Reports 2020; 13(4): e228818 doi: 10.1136/bcr-2018-228818
7
Mizuki Watanabe, Junya Kanda, Masakatsu Hishizawa, Momoko Nishikori, Tadakazu Kondo, Kouhei Yamashita, Akifumi Takaori-Kondo. Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disordersAnnals of Hematology 2020; 99(7): 1565 doi: 10.1007/s00277-020-04084-5
8
Thaninee Prasoppokakorn, Thammathorn Assanasen, Poonchavist Chantranuwatana, Chusana Suankratay. EBV-associated lymphoid interstitial pneumonia in IBD patient: Case report and literature reviewRespiratory Medicine Case Reports 2020; 30: 101059 doi: 10.1016/j.rmcr.2020.101059
9
Justin T. Kelley, Anna B. Owczarczyk, David O. Ferguson, Winston Y. Lee, Daniel A. Arber, Laura W. Lamps. Post-transplant lymphoproliferative disorder with ileal stricture masquerading as Crohn diseaseHuman Pathology Reports 2022; 28: 300654 doi: 10.1016/j.hpr.2022.300654
10
Andrea Núñez Ortiz, María Rojas Feria, María Dolores de la Cruz Ramírez, Lourdes Gómez Izquierdo, Claudio Trigo Salado, José Manuel Herrera Justiniano, Eduardo Leo Carnerero. Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomesRevista Española de Enfermedades Digestivas 2021;  doi: 10.17235/reed.2021.7915/2021
11
Katarzyna Stasik, Rafał Filip. The Complex Relationship between Mechanisms Underlying Inflammatory Bowel Disease, Its Treatment, and the Risk of Lymphomas: A Comprehensive ReviewInternational Journal of Molecular Sciences 2024; 25(8): 4241 doi: 10.3390/ijms25084241
12
Cristina Saldaña Dueñas, Cristina Rodríguez Gutiérrez. Neutropenia por linfocitos grandes granulares secundaria a adalimumab y reactivación de mononucleosis: reporte de un caso y revisión de la literaturaGastroenterología y Hepatología 2020; 43(8): 446 doi: 10.1016/j.gastrohep.2020.02.012
13
Sufang Tian, Lindsey M. Westbrook, Shu-Yuan Xiao, Yanlin Zhang, Yan Huang, Hanlin L. Wang. The Morphologic Features of Primary Epstein-Barr Virus Infection in the Gastrointestinal TractAmerican Journal of Surgical Pathology 2019; 43(9): 1253 doi: 10.1097/PAS.0000000000001319
14
John Ward, Ariela Noy, Gary Ulaner, Christopher Riedl. Adalimumab-Induced Epstein-Barr Virus–Related Lymphoproliferative Disorder on FDG PET/CTClinical Nuclear Medicine 2018; 43(5): 344 doi: 10.1097/RLU.0000000000002054
15
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood. Use of thiopurines in inflammatory bowel disease: an updateIntestinal Research 2022; 20(1): 11 doi: 10.5217/ir.2020.00155
16
Cristina Saldaña Dueñas, Cristina Rodríguez Gutiérrez. Neutropenia induced by large granular lymphocytes secondary to adalimumab and reactivated mononucleosis: case report and literature reviewGastroenterología y Hepatología (English Edition) 2020; 43(8): 446 doi: 10.1016/j.gastre.2020.02.012
17
Cosimo Cumbo, Francesco Tarantini, Antonella Zagaria, Luisa Anelli, Crescenzio Francesco Minervini, Nicoletta Coccaro, Giuseppina Tota, Luciana Impera, Elisa Parciante, Maria Rosa Conserva, Immacolata Redavid, Paola Carluccio, Mario Delia, Annamaria Giordano, Maria Chiara Longo, Tommasina Perrone, Antonella Russo Rossi, Giorgina Specchia, Pellegrino Musto, Francesco Albano. Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.873896
18
Andrea Bilger, Julie Plowshay, Shidong Ma, Dhananjay Nawandar, Elizabeth A. Barlow, James C. Romero-Masters, Jillian A. Bristol, Zhe Li, Ming-Han Tsai, Henri-Jacques Delecluse, Shannon C. Kenney. Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replicationOncotarget 2017; 8(27): 44266 doi: 10.18632/oncotarget.17863
19
Lisa Tsang, Natasha Banerjee, James H. Tabibian. Bloody Diarrhea and Weight Loss in a Patient in Remission From Ulcerative ColitisGastroenterology 2019; 157(5): 1207 doi: 10.1053/j.gastro.2019.01.272